Package 83324-120-25

Brand: olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic
NDC Package

Package Facts

Identity

Package NDC 83324-120-25
Digits Only 8332412025
Product NDC 83324-120
Product ID 83324-120_69a4a96f-dad6-28a7-1dc2-985ccdc80e36
Description

1 BOTTLE, PLASTIC in 1 CARTON (83324-120-25) / 2.5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2024-09-03
Brand olopatadine hydrochloride ophthalmic solution
Generic olopatadine hydrochloride ophthalmic
Sample Package No

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "69a4a96f-dad6-28a7-1dc2-985ccdc80e36", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["56d4b17c-bc5d-0734-32c9-bb10ec77f7b4"], "manufacturer_name": ["Chain Drug Marketing Association INC"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (83324-120-25)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "83324-120-25", "marketing_start_date": "20240903"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "83324-120_69a4a96f-dad6-28a7-1dc2-985ccdc80e36", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "83324-120", "generic_name": "Olopatadine Hydrochloride Ophthalmic", "labeler_name": "Chain Drug Marketing Association INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209752", "marketing_category": "ANDA", "marketing_start_date": "20210101", "listing_expiration_date": "20261231"}